AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Platepag ML 25mg Tablet

Prescription Icon
Prescription Required

Marketer

Metta Life Sciences Private Limited

Salt Composition

Eltrombopag (25mg)

Overview Platepag ML 25mg Tablet

Eltrombopag 25mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or persistent hepatitis C virus (HCV) infection. This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, eltrombopag boosts platelet production. Platelets are crucial for hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. Administration on an empty stomach is acceptable. Swallow the tablet whole; do not crush, chew, or break it. Report any known drug allergies to your doctor. Commonly reported adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Discuss any bothersome side effects with your doctor; management strategies may be available. Prior to commencing treatment, disclose any pre-existing health issues and all concurrent medications. Dosage modifications might be necessary for individuals with hepatic impairment; consult your doctor.

Uses of Platepag ML 25mg Tablet

Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical bone marrow failure

Major Benefits of Platepag ML 25mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Platepag ML 25mg Tablet on an empty stomach.

Common Side effects of Platepag ML 25mg Tablet:

  • Nausea
  • Diarrhea
  • Upper respiratory tract infection
  • Vomiting
  • Increased liver enzymes
  • Muscle pain
  • Urinary tract infection

How to use Platepag ML 25mg Tablet:

Your physician will determine the correct dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Platepag ML 25mg Tablets should be taken on an empty stomach.

How Platepag ML 25mg Tablet works:

The thrombocytopenia medication Platepag ML 25mg Tablet acts as a thrombopoietin receptor activator, boosting platelet production within the bloodstream. This increase in platelets aids in minimizing or preventing hemorrhaging.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Platepag ML 25mg Tablet lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Platepag ML 25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Platepag ML 25mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Platepag ML 25mg Tablet, which can induce dizziness and other side effects that reduce alertness.

KidneyKidneySAFE IF PRESCRIBED

The use of Platepag ML 25mg Tablet is considered safe for individuals with kidney impairment; dosage modification is typically unnecessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function is advised during treatment with this medication.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Platepag ML 25mg Tablets. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Platepag ML 25mg Tablet :

Omit any missed dose of Platepag ML 25mg Tablet and resume your regular dosing regimen. Avoid taking a double dose.

Facts to Know About Platepag ML 25mg Tablet

LabelValue
Chemical Category Biphenyl Derivatives
Developing Habits No.
Type of Therapy KINSHIP
Active Class Thrombopoietin receptor activator

FAQs on Platepag ML 25mg Tablet

Platepag ML 25mg tablets raise blood platelet counts. Follow your doctor's instructions precisely. Swallow the tablet whole with water; do not crush or chew it.
Take Platepag ML 25mg tablets precisely as directed by your physician. Administer the medication on an empty stomach, either one hour before or two hours after meals. Never change the dosage or frequency without your doctor's explicit instructions.
Platepag ML 25mg Tablets help prevent bleeding by raising blood platelet counts. The onset of effectiveness varies individually, but a response typically appears within two weeks.
To ensure Platepag ML 25mg Tablet works effectively, avoid dairy products (like cheese and butter) and vitamin/mineral supplements for six hours—four hours before and two hours after taking the tablet. Consuming these items concurrently may hinder the medication's absorption.
Store this medication at room temperature, between 20°C and 25°C. Keep the bottle tightly closed and leave the desiccant pack inside, if included, to maintain dryness.
Platepag ML 25mg Tablets may cause serious liver damage, indicated by yellow skin or eyes, upper right abdominal pain, dark urine, and fatigue. This risk is higher in patients with hepatitis C. The medication can also raise platelet counts, increasing the risk of blood clots, heart attack, stroke, and even death. Regular blood tests to monitor liver function and platelet levels are recommended. Furthermore, Platepag ML 25mg Tablets may worsen cataracts, causing blurred vision. Seek immediate medical attention for any of these side effects.
Missed a Platepag ML 25mg Tablet dose? Wait and take your next scheduled dose; don't double up. Taking more than one dose daily increases the risk of side effects.
Platepag ML 25mg Tablet
1,477
MRP 1,800
17% off